SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-110564
Filing Date
2024-10-01
Accepted
2024-10-01 08:54:42
Documents
12
Period of Report
2024-09-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K neog-20240925.htm   iXBRL 8-K 40291
2 EX-99.1 neog-ex99_1.htm EX-99.1 5608
  Complete submission text file 0000950170-24-110564.txt   161739

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT neog-20240925.xsd EX-101.SCH 25023
14 EXTRACTED XBRL INSTANCE DOCUMENT neog-20240925_htm.xml XML 4730
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

IRS No.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-17988 | Film No.: 241341460
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)